Literature DB >> 1373201

5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate.

V K Pathak1, H M Temin.   

Abstract

A broad spectrum of mutations occurs at a high rate during a single round of retrovirus replication (V.K. Pathak and H. M. Temin, Proc. Natl. Acad. Sci. USA 87:6019-6023, 1990). We have now determined that this high rate of spontaneous mutation can be further increased by 5-azacytidine (AZC) treatment or by regions of potential RNA secondary structure. We found a 13-fold increase in the mutation rate after AZC treatment of retrovirus-producing cells and target cells. The AZC-induced substitutions were located at the same target sites as previously identified spontaneous substitutions. The concordance of the AZC-induced and spontaneous substitutions indicates the presence of reverse transcription "pause sites," where the growing point is error prone. An analysis of nucleotides that neighbored substitutions revealed that transversions occur primarily by transient template misalignment, whereas transitions occur primarily by misincorporation. We also introduced a 34-bp potential stem-loop structure as an in-frame insertion within a lacZ alpha gene that was inserted in the long terminal repeat (LTR) U3 region and determined whether this potential secondary structure increased the rate of retrovirus mutations. We found a threefold increase in the retrovirus mutation rate. Fifty-seven of 96 mutations were deletions associated with the potential stem-loop. We also determined that these deletion mutations occurred primarily during minus-strand DNA synthesis by comparing the frequencies of mutations in recovered provirus plasmids containing both LTRs and in provirus plasmids containing only one LTR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373201      PMCID: PMC241071     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer.

Authors:  G A Pulsinelli; H M Temin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  High efficiency transformation of E. coli by high voltage electroporation.

Authors:  W J Dower; J F Miller; C W Ragsdale
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

4.  5-Azacytidine: a new active agent for the treatment of acute leukemia.

Authors:  M Karon; L Sieger; S Leimbrock; J Z Finklestein; M E Nesbit; J J Swaney
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

5.  Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.

Authors:  L H Li; E J Olin; H H Buskirk; L M Reineke
Journal:  Cancer Res       Date:  1970-11       Impact factor: 12.701

6.  Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine.

Authors:  N Bouck; D Kokkinakis; J Ostrowsky
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

7.  Effect of 5-azacytidine (5-azaC) on the induction of chromatid aberrations (CA) and sister-chromatid exchanges (SCE).

Authors:  P Lavia; M Ferraro; A Micheli; G Olivieri
Journal:  Mutat Res       Date:  1985-05       Impact factor: 2.433

8.  The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation.

Authors:  T A Kunkel; P S Alexander
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

9.  Genetic effects of 5-azacytidine in Saccharomyces cerevisiae.

Authors:  F K Zimmermann; I Scheel
Journal:  Mutat Res       Date:  1984-01       Impact factor: 2.433

10.  Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity.

Authors:  L Olsson; J Forchhammer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  52 in total

1.  Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.

Authors:  E S Svarovskaia; K A Delviks; C K Hwang; V K Pathak
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity.

Authors:  A Grande-Pérez; S Sierra; M G Castro; E Domingo; P R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-05       Impact factor: 11.205

4.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

5.  Chaos and order in spontaneous mutation.

Authors:  John W Drake
Journal:  Genetics       Date:  2006-05       Impact factor: 4.562

6.  Pausing during reverse transcription increases the rate of retroviral recombination.

Authors:  Christian Lanciault; James J Champoux
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Replication of the retroviral terminal repeat sequence during in vivo reverse transcription.

Authors:  C A Ramsey; A T Panganiban
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 8.  Molecular evolution of aphthoviruses.

Authors:  E Domingo; M G Mateu; C Escarmís; E Martínez-Salas; D Andreu; E Giralt; N Verdaguer; I Fita
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction.

Authors:  M A Martínez; M Sala; J P Vartanian; S Wain-Hobson
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.